RxDoctor Payments Data

Travis Batts

Cardiovascular Disease · Jbsa Lackland, TXNPI 1164646394

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $376,504 of the $457,023 with a category attached, or 82.4%. Philips North America LLC accounts for 64.0% of it on its own, with 6 other manufacturers making up the rest. Among cardiovascular disease clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$457,023in general payments, 2019–2025

Across 434 payments — averaging $1053.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$293K
  • Novo Nordisk$164K
  • Edwards Lifesciences$221
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$106
  • Chiesi USA, Inc.$98
  • Pfizer$87
  • plus $18 from 1 others

What the payments were for

  • Consulting fees$20,9855%
  • Speaking & faculty fees$376,50482%
  • Travel & lodging$50,34411%
  • Food & beverage$9,1252%
  • Education$650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$457,023 in reported general payments places this provider in the 95th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas

Other cardiovascular disease in Jbsa Lackland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →